CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer

Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han

Cancer Research and Treatment. 2017;49(4):1001-1011. Published online 2017 January 13 DOI: https://doi.org/10.4143/crt.2016.546

Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer

Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han

Cancer Research and Treatment. 2017;49(4):1001-1011

Link1

Link2 Link3

Afatinib in patients with advanced non-small cell lung cancer harboring HER2 mutations, previously treated with chemotherapy: A phase II trial

Yun Fan, Jianhua Chen, Chengzhi Zhou, Huijuan Wang, Yongqian Shu, Jacky Zhang, Hairui Hua, Dennis Chin-Lun Huang, Caicun Zhou

Lung Cancer. 2020;147:209-213

Link1 Link2

Results of a clinical multicentric randomized phase II study of non-small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone

Lung Cancer. 1995;12(3):307

Link1 Link2

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

A.S. Tsao

Yearbook of Oncology. 2012;2012:187-188

Link1 Link2

A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

Hisao Imai, Kyoichi Kaira, Kensuke Suzuki, Masaki Anzai, Takeshi Tsuda, Tamotsu Ishizuka, Tomohito Kuwako, Ichiro Naruse, Kenji Nemoto, Junji Uchino, Nobutoshi Morozumi, Shinichi Ishihara, Koichi Minato, Takeshi Hisada

Lung Cancer. 2018;126:41-47

Link1 Link2

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer

Koichi Takayama, Masao Ichiki, Shoji Tokunaga, Koji Inoue, Masayuki Kawasaki, Junji Uchino, Yoichi Nakanishi

The Oncologist. 2019;24(11):1420-e1010

Link1 Link2 Link3

Link4

Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer

Lung Cancer. 1993;8(5-6):348

Link1 Link2

Afatinib treatment in advanced non-small cell lung cancer

Lynn Campbell, Hurwitz, Scullin

Lung Cancer: Targets and Therapy. 2011;47

Link1

Randomized study of NavelbineR and cisplatin versus vindesine and cisplatin versus NavelbineR alone in 612 patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer. 1996;16(1):120

Link1 Link2

Comment on ‘Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer’—No support for de-escalation of immunotherapy

Alexandros Georgiou, Anna Minchom, Mary O'Brien

European Journal of Cancer. 2019;115:24-26

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.